Gene · 668
Papers2,198
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,198
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of ERβ in the ovary and ovary related diseases. | Gene | 2024 | 38906392 | PubTator, text mining | PubMed |
| An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers. | Virchows Arch | 2024 | 38904760 | PubTator, text mining | PubMed |
| Bibliometric analysis of kinship analysis from 1960 to 2023: global trends and development. | Front Genet | 2024 | 38903754 | PubTator, text mining | PubMed |
| Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors. | Cancer Med | 2024 | 38898688 | PubTator, text mining | PubMed |
| Corrigendum: Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome. | Front Genet | 2024 | 38742166 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis. | J Pathol Clin Res | 2024 | 38661052 | PubTator, text mining | PubMed |
| Modeling interpretable correspondence between cell state and perturbation response with CellCap. | bioRxiv | 2024 | 38558987 | PubTator, text mining | PubMed |
| Shifting the landscape: Dominant C-terminal rare missense FOXL2 variants in non-syndromic primary ovarian failure etiology. | Clin Genet | 2024 | 38558253 | PubTator, text mining | PubMed |
| Decoding the epigenetic mechanism of mammalian sex determination. | Exp Cell Res | 2024 | 38531506 | PubTator, text mining | PubMed |
| A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. | Br J Cancer | 2024 | 38429437 | PubTator, text mining | PubMed |
| Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis. | J Alzheimers Dis | 2024 | 38427479 | PubTator, text mining | PubMed |
| Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications. | Int J Gynecol Pathol | 2024 | 38426544 | PubTator, text mining | PubMed |
| Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome. | Front Genet | 2024 | 38410153 | PubTator, text mining | PubMed |
| Review on Sertoli-Leydig Cell Tumours of the Ovary. | Discov Med | 2024 | 38409829 | PubTator, text mining | PubMed |
| [Clinicopathological analysis of gonadal differentiation of sex development disorder]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38281784 | PubTator, text mining | PubMed |
| Uterine Tumors Resembling Ovarian Sex Cord Tumors (UTROSCTs): A Scoping Review of 511 Cases, Including 2 New Cases. | Medicina (Kaunas) | 2024 | 38276058 | PubTator, text mining | PubMed |
| Baicalin enhances proliferation and reduces inflammatory-oxidative stress effect in H2O2-induced granulosa cells apoptosis via USP48 protein regulation. | BMC Complement Med Ther | 2024 | 38245760 | PubTator, text mining | PubMed |
| Ovotesticular cords and ovotesticular follicles: New histologic markers for human ovotesticular syndrome. | J Pediatr Urol | 2024 | 38218629 | PubTator, text mining | PubMed |
| Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary. | Sci Rep | 2024 | 38200105 | PubTator, text mining | PubMed |
| FOXL2 and NR5A1 induce human fibroblasts into steroidogenic ovarian granulosa-like cells. | Cell Prolif | 2024 | 38192172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/668/papers?page=7